Diffusion Models Drive Advances in Drug Discovery, Not Just LLMs

Jul 11, 2026

Recent research highlights that some of the most exciting progress in diffusion models is happening outside of large language models (LLMs), particularly in drug discovery. Genesis Molecular AI's work, including PEARL's zero-shot OpenBind achievement and advances in protein co-folding accuracy, is opening new possibilities in molecular science. The trend is attracting top talent from major AI labs to the biotech sector.

Why it matters: These advances could accelerate drug discovery and transform molecular biology by leveraging AI beyond text generation.

Full story at: Latent Space ↗